SEARCH RESULTS FOR: "Tag: NVAX"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2022(9)
2021(8)
2020(8)
2019(3)
2018(3)
2016(6)
2015(5)
CATEGORIES
5-Minute Market Rundown(6)
Analyst Downgrades(2)
Analyst Update(6)
Bernie's Content(2)
Buzz Stocks(13)
Editor's Pick(2)
Expectational Analysis(1)
General(2)
Intraday Option Activity(4)
Midday Market Check(3)
Opening View(2)
Quantitative Analysis(1)
Stock Market News(1)
Stocks On the Move(4)
The Week Ahead(1)

11/18/2022 10:12 AM
Novavax Inc. (NASDAQ:NVAX) just received expanded authorization in Canada for its Covid-19 booster. Regulators in the country have approved the shot for adults in the country that were previously immu...
11/9/2022 10:31 AM
Novavax Inc. (NASDAQ:NVAX) stock is up 4.2% to trade at $20.48 this morning. While the drugmaker missed third-quarter profit estimates after posting losses of $2.15 per share, revenue of $735 million ...
9/23/2022 12:48 PM
While the central bank has been anything but shy about its hawkish intentions, investors seem convinced that the aggressive rate hikes are putting the economy on track for a recession. As such, purs...
9/22/2022 9:42 AM
The shares of Novavax, Inc. (NASDAQ:NVAX) are 4.9% lower this morning, last seen trading at $24.60, following a bear note from J.P. Morgan Securities. The firm downgraded NVAX to "underweight" from "...
7/19/2022 1:00 AM
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company’s protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U...